NVO

Novo Nordisk

Exchange: NYSESector: HealthcareIndustry: Biotechnology

Values in USD · ADR · Reports in DKK

Novo Nordisk is a leading global health care company that's been making innovative medicines to help people with diabetes lead longer, healthier lives for more than 100 years. This heritage has given us experience and capabilities that also enable us to drive change to help people defeat other serious chronic diseases such as obesity, rare blood, and endocrine disorders. We remain steadfast in our conviction that the formula for lasting success is to stay focused, think long-term, and do business in a financially, socially, and environmentally responsible way.

Current Price

—

GoodMoat Value

$87.03

Profile

Valuation (TTM)

Market Cap—

P/E—

EV—

P/B—

Shares Out—

P/Sales—

Revenue—

EV/EBITDA—

Novo Nordisk (NVO) Company Profile

NVO Company Information

Novo Nordisk is a leading global health care company that's been making innovative medicines to help people with diabetes lead longer, healthier lives for more than 100 years.

This heritage has given us experience and capabilities that also enable us to drive change to help people defeat other serious chronic diseases such as obesity, rare blood, and endocrine disorders.

We remain steadfast in our conviction that the formula for lasting success is to stay focused, think long-term, and do business in a financially, socially, and environmentally responsible way.

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSE

Country

Denmark

NVO Key Officers

Key officers data coming soon

NVO Company Profile

Novo Nordisk (NVO) is a Healthcare company in the Biotechnology industry. It trades on NYSE. The company is based in Denmark.

See the full Novo Nordisk profile on GoodMoat. It covers key officers, financial metrics, and sector details. You can also use GoodMoat's DCF calculator, fair value models, and quality score to help decide if NVO is a good investment.